Asset Details
Do you wish to reserve the book?
Microvascular impairment as a biomarker of diabetic retinopathy progression in the long-term follow up in type 1 diabetes
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Microvascular impairment as a biomarker of diabetic retinopathy progression in the long-term follow up in type 1 diabetes
Do you wish to request the book?
Microvascular impairment as a biomarker of diabetic retinopathy progression in the long-term follow up in type 1 diabetes
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Microvascular impairment as a biomarker of diabetic retinopathy progression in the long-term follow up in type 1 diabetes
2020
Overview
This study aimed to explore differences in vascular and structural parameters using optical coherence tomography angiography in patients with type 1 diabetes (DM1) with mild signs of diabetic retinopathy (DR) over a two-year follow-up period. Parafoveal vessel density (PVD) and foveal avascular zone (FAZ) area were analyzed. The thickness of three predefined retinal slabs was measured, including the inner limiting membrane (ILM)–inner plexiform layer (IPL), IPL–inner nuclear layer (INL), and the IPL–outer nuclear layer (ONL). Twenty-two patients with DM1 and 21 controls were included. There was no significant difference in the FAZ area, perimeter and acircularity index between cohorts over time. Baseline superficial capillary plexus PVD was approximately 10% lower in patients with diabetes than in controls (
p
= 0.001), and was 12% lower at 2 years (
p
= 0.002). There was no difference in the annual linear trend between the groups (− 0.5% in diabetics vs. controls,
p
= 0.736). Baseline deep capillary plexus (DCP) PVD was slightly lower in diabetics than in controls (− 4.4%,
p
= 0.047) and the difference increased at 2 years (− 12.6%,
p
< 0.001). The annual linear trend was − 2.7% in diabetic patients compared to controls (
p
= 0.009)
.
In addition, the PVD of the DCP and the intermediate capillary plexus (ICP) were evaluated separately. Regarding the DCP PVD, no statistically significant difference at any time points in diabetic patients compared to controls and no statistically significant difference in the linear trend was found (
p
> 0.1). Conversely, no difference was recorded for parafoveal ICP density at individual time points (
p
> 0.1), but a statistically significant difference in the linear trend over time in diabetic patients compared to controls was recoded (− 3.2% per year,
p
= 0.001). Despite the apparent intergroup differences at baseline in structural OCT parameters, the differences including ILM–IPL (
p
= 0.273), IPL–INL (
p
= 0.708), and IPL–ONL (
p
= 0.054) were modest and not statistically significant with time. Therefore, the microvascular change of the deeper vessels might be a robust biomarker to evaluate the clinical progression of DR in DM1.
Publisher
Nature Publishing Group UK,Nature Publishing Group
Subject
/ 692/699
/ Adult
/ Diabetes
/ Diabetes mellitus (insulin dependent)
/ Diabetes Mellitus, Type 1 - complications
/ Diabetes Mellitus, Type 1 - diagnostic imaging
/ Diabetic Retinopathy - diagnostic imaging
/ Female
/ Fovea Centralis - blood supply
/ Fovea Centralis - diagnostic imaging
/ Humanities and Social Sciences
/ Humans
/ Male
/ Retinal Vessels - diagnostic imaging
/ Science
